Replies to post #20369 on Relief Therapeutics Holding AG (RLFTF)

[nelskof]

I believe several of these therapeutics will ultimately be used together... like a HMAB with Aviptadil, especially since VIP is naturally occurring in the body. For example, the NIH already selected a combo of Lenzilumab and Remdesivir for a sponsored BET trial that is starting soon (even though Rem is barely effective). I imagine by 1/1/21 we will have inhalers, shots and IV solutions available to work in conjunction with each other. I hope it will lower the death rates to that of the flu or lower and we can all get back to normal.